Lymphocyte-facilitated tumour cell adhesion to endothelial cells: The role of high affinity leucocyte integrins

Pathology

Volumn 35, Issue 1, 2003, Pages 50-55

  Neeson, Paul J ^a,d   Thurlow, Peter J ^a   Jamieson, Gary P ^b   Bradley, Chris ^c  

^a Immunology Unit   (Australia)

^b AUSTIN RESEARCH INSTITUTE   (Australia)

^c LA TROBE UNIVERSITY   (Australia)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Intercellular adhesion molecule 1; Leucocyte function antigen 1; Phorbol myristate acetate; Tumor cell; Tumour cell

Indexed keywords

ANTIBODY; BETA1 INTEGRIN; CHROMIUM 51; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; L SELECTIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; SULFUR 35; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; BINDING ASSAY; CELL ADHESION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LYMPHOCYTE; PROTEIN BINDING;

EID: 0037299964     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313020307517     Document Type: Article

References (26)

1. Binnerts M, van Kooyk Y, Simmons D, Figdor C. Distinct binding of T lymphocytes to ICAM-1, -2 or -3 upon activation of LFA-1. Eur J Immunol 1994; 24: 2155-60.
2. Hogg N, Harvey J, Cabanas C, Landis R. Control of leukocyte integrin activation. Am Rev Respir Dis 1993; 148: S55-9.
3. Knorr R, Dustin M. The lymphocyte function-associated antigen 1 I domain is a transient binding module for intercellular adhesion molecule (ICAM)-1 and ICAM-3 in hydrodynamic flow. J Exp Med 1997; 186: 719-30.
4. Landis R, Bennett R, Hogg N. A novel LFA-1 activation epitope maps to the I domain. J Cell Biol 1993; 120: 1519-27.
5. Landis R, McDowall A, Holness C, Littler A, Simmons D, Hogg N. Involvement of the 'I' domain of LFA-1 in selective binding to ligands ICAM-1 and ICAM-3. J Cell Biol 1994; 126: 529-37.
6. Stewart M, Cabanas C, Hogg N. T cell adhesion to intercellular adhesion molecule-1 (ICAM-1) is controlled by cell spreading and the activation of integrin LFA-1. J Immunol 1996; 156: 1810-7.
7. Dransfield I, Cabanas C, Craig A, Hogg N. Divalent cation regulation of the function of the leukocyte integrin LFA-1. J Cell Biol 1992; 116: 219-26.
8. Cabanas C, Hogg N. Ligand intercellular adhesion molecule 1 has a necessary role in activation of integrin lymphocyte function-associated molecule 1. (Published erratum appears in Proc Natl Acad Sci USA 1993; 90: 8302.) Proc Natl Acad Sci USA 1993; 90: 5838-42.
9. Pober JS, Gimbrone MA Jr, Lapierre LA, et al. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 1986; 137: 1893-6.
10. Pober JS, Lapierre LA, Stolpen AH, et al. Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species. J Immunol 1987; 138: 3319-24.
11. Pober J, Cotran R. Cytokines and endothelial cell biology. Physiol Rev 1990; 70: 427-51.
12. Pober J, Cotran R. The role of endothelial cells in inflammation. Transplantation 1990; 50: 537-44.
13. Pober JS, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev 1990; 70: 427-51.
14. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52: 2745-56.
15. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 1968; 97: 77-89.
16. Cantrell D, Smith K. The interleukin-2 T-cell system: a new cell growth model. Science 1984; 224: 1312-6.
17. Neeson PJ, Thurlow PJ, Jamieson GP. Characterization of activated lymphocyte-tumor cell adhesion. J Leukoc Biol 2000; 67: 847-55.
18. Stewart M, Hogg N. Regulation of leukocyte integrin function: affinity vs. avidity. J Cell Biochem 1996; 61: 554-61.
19. Pober JS, Bevilacqua MP, Mendrick DL, Lapierre LA, Fiers W, Gimbrone MA Jr. Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J Immunol 1986; 136: 1680-7.
20. Pober JS, Lapierre LA, Stolpen AH, et al. Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species. J Immunol 1987; 138: 3319-24.
21. Oppenheimer-Marks N, Davis L, Lipsky P. Human T lymphocyte adhesion to endothelial cells and transendothelial migration. Alteration of receptor use relates to the activation status of both the T cell and the endothelial cell. J Immunol 1990; 145: 140-8.
22. Shimizu Y, Newman W, Gopal T, et al. Four molecular pathways of T cell adhesion to endothelial cells: roles of LFA-1, VCAM-1, and ELAM-1 and changes in pathway hierarchy under different activation conditions. J Cell Biol 1991; 113: 1203-12.
23. Narita T, Kawakami-Kimura N, Sato M, et al. Biological functions of cell adhesion molecules in breast cancer. Gan To Kagaku Ryoho 1996; 23 (Suppl 1): 56-60.
24. Lauri D, Martin-Padura I, Biondelli T, et al. Role of beta 1 integrins in tumor cell adhesion to cultured human endothelial cells. Lab Invest 1991; 65: 525-31.
25. Rice G, Bevilacqua M. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science 1989; 246: 1303-6.
26. Narita T, Kawakami-Kimura N, Sato M, et al. Alteration of integrins by heparin-binding EGF-like growth factor in human breast cancer cells. Oncology 1996; 53: 374-81.